ArticleJournal of clinical medicine2025

Revisiting Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Evidence of Survival Benefit with First-Line Immunotherapy and Targeted Therapy Regimens.

Sri Saran Manivasagam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.